Budesonide prevents but does not reverse sustained airway hyperresponsiveness in mice

European Respiratory Journal

Volumn 32, Issue 4, 2008, Pages 970-978

  Southam, D S ^a   Ellis, R ^a   Wattie, J ^a   Young, S ^b   Inman, M D ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Airway hyperresponsiveness; Asthma; Bronchial hyperreactivity; Corticosteroid treatment; Pathophysiology; Remodelling

Indexed keywords

ALLERGEN; BUDESONIDE;

AIRWAY CONSTRICTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE COURSE; DRUG EFFECT; EXPOSURE; FEMALE; LONG TERM CARE; LOW DRUG DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THERAPY DELAY; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ALLERGENS; ANIMALS; BRONCHODILATOR AGENTS; BUDESONIDE; COLLAGEN; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION; LUNG; MICE; MICE, INBRED BALB C; RESPIRATORY HYPERSENSITIVITY; TIME FACTORS; TREATMENT OUTCOME;

EID: 58849085091     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00125307     Document Type: Article

References (44)

1. Cockcroft DW, Killian DN, Mellon JJ, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977; 7: 235-243.
2. O'Byrne PM, Inman MD. Airway hyperresponsiveness. Chest 2003; 123: Suppl. 3, 411S-416S.
3. Laprise C, Laviolette M, Boutet M, Boulet LP. Asymptomatic airway hyperresponsiveness: relationships with airway inflammation and remodelling. Eur Respir J 1999; 14: 63-73.
4. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000; 105: 651-663.
5. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323: 1033-1039.
6. Woodruff PG, Khashayar R, Lazarus SC, et al. Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma. J Allergy Clin Immunol 2001; 108: 753-758.
7. Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB. Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989; 140: 1745-1753.
8. Pepe C, Foley S, Shannon J, et al. Differences in airway remodeling between subjects with severe and moderate asthma. J Allergy Clin Immunol 2005; 116: 544-549.
9. Boulet LP, Laviolette M, Turcotte H, et al. Bronchial subepithelial fibrosis correlates with airway responsiveness to methacholine. Chest 1997; 112: 45-52.
10. O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med 2001; 164: 1392-1397.
11. Hansel TT. How do we measure the effectiveness of inhaled corticosteroids in clinical studies? Respir Med 2004; 98: Suppl. B, S9-S15.
12. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000; 343: 332-336.
13. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994; 88: 373-381.
14. Selroos O, Pietinalho A, Lofroos AB, Riska H. Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest 1995; 108: 1228-1234.
15. Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006; 354: 1985-1997.
16. Bergeron C, Hauber HP, Gotfried M, et al. Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide. J Allergy Clin Immunol 2005; 116: 983-989.
17. Laitinen A, Altraja A, Kampe M, Linden M, Virtanen I, Laitinen LA. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med 1997; 156: 951-958.
18. Redington AE, Springall DR, Meng QH, et al. Immunoreactive endothelin in bronchial biopsy specimens: increased expression in asthma and modulation by corticosteroid therapy. J Allergy Clin Immunol 1997; 100: 544-552.
19. Hoshino M, Takahashi M, Takai Y, Sim J. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J Allergy Clin Immunol 1999; 104: 356-363.
20. Bergeron C, Boulet LP. Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation. Chest 2006; 129: 1068-1087.
21. McMillan SJ, Xanthou G, Lloyd CM. Therapeutic administration of budesonide ameliorates allergen-induced airway remodelling. Clin Exp Allergy 2005; 35: 388-396.
22. Cho JY, Miller M, McElwain K, McElwain S, Broide DH. Combination of corticosteroid therapy and allergen avoidance reverses allergen-induced airway remodeling in mice. J Allergy Clin Immunol 2005; 116: 1116-1122.
23. Vanacker NJ, Palmans E, Pauwels RA, Kips JC. Fluticasone inhibits the progression of allergen-induced structural airway changes. Clin Exp Allergy 2002; 32: 914-920.
24. Woolcock AJ, Yan K, Salome CM. Effect of therapy on bronchial hyperresponsiveness in the long-term management of asthma. Clin Allergy 1988; 18: 165-176.
25. Jeffery PK, Godfrey RW, Adelroth E, Nelson F, Rogers A, Johansson SA. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. Am Rev Respir Dis 1992; 145: 890-899.
26. Boulet LP, Turcotte H, Laviolette M, et al. Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Influence of inhaled corticosteroids. Am J Respir Crit Care Med 2000; 162: 1308-1313.
27. Kim J, McKinley L, Siddiqui J, Bolgos GL, Remick DG. Prevention and reversal of pulmonary inflammation and airway hyperresponsiveness by dexamethasone treatment in a murine model of asthma induced by house dust. Am J Physiol Lung Cell Mol Physiol 2004; 287: L503-L509.
28. Chu HW, Campbell JA, Rino JG, Harbeck RJ, Martin RJ. Inhaled fluticasone propionate reduces concentration of Mycoplasma pneumoniae, inflammation, and bronchial hyperresponsiveness in lungs of mice. J Infect Dis 2004; 189: 1119-1127.
29. Inman MD, Watson RM, Rerecich T, et al. Dose-dependent effects of inhaled mometasone furoate on airway function and inflammation after allergen inhalation challenge. Am J Respir Crit Care Med 2001; 164: 569-574.
30. Gauvreau GM, Sulakvelidze I, Watson RM, Inman MD, Rerecich TJ, O'Byrne PM. Effects of once daily dosing with inhaled budesonide on airway hyperresponsiveness and airway inflammation following repeated low-dose allergen challenge in atopic asthmatics. Clin Exp Allergy 2000; 30: 1235-1243.
31. Leigh R, Vethanayagam D, Yoshida M, et al. Effects of montelukast and budesonide on airway responses and airway inflammation in asthma. Am J Respir Crit Care Med 2002; 166: 1212-1217.
32. Leigh R, Ellis R, Wattie J, et al. Dysfunction and remodeling of the mouse airway persist after resolution of acute allergen-induced airway inflammation. Am J Respir Cell Mol Biol 2002; 27: 526-535.
33. Leigh R, Ellis R, Wattie JN, et al. Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodeling in mice. Am J Respir Crit Care Med 2004; 169: 860-867.
34. Leigh R, Southam DS, Ellis R, et al. T-cell-mediated inflammation does not contribute to the maintenance of airway dysfunction in mice. J Appl Physiol 2004; 97: 2258-2265.
35. Inman MD, Ellis R, Wattie J, Denburg JA, O'Byrne PM. Allergen-induced increase in airway responsiveness, airway eosinophilia, and bone-marrow eosinophil progenitors in mice. Am J Respir Cell Mol Biol 1999; 21: 473-479.
36. Ellis R, Leigh R, Southam D, O'Byrne PM, Inman MD. Morphometric analysis of mouse airways after chronic allergen challenge. Lab Invest 2003; 83: 1285-1291.
37. Vanacker NJ, Palmans E, Pauwels RA, Kips JC. Dose-related effect of inhaled fluticasone on allergen-induced airway changes in rats. Eur Respir J 2002; 20: 873-879.
38. Lemiere C, Bai T, Balter M, et al. Adult Asthma Consensus Guidelines Update 2003. Can Respir J 2004; 11: Suppl. A, 9A-18A.
39. Pauwels RA, Pedersen S, Busse WW,et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 2003; 361: 1071-1076.
40. Gronke L, Kanniess F, Holz O, Jorres RA, Magnussen H. The relationship between airway hyper-responsiveness, markers of inflammation and lung function depends on the duration of the asthmatic disease. Clin Exp Allergy 2002; 32: 57-63.
41. Miller M, Cho JY, McElwain K, et al. Corticosteroids prevent myofibroblast accumulation and airway remodeling in mice. Am J Physiol Lung Cell Mol Physiol 2006; 290: L162-L169.
42. Southam DS, Ellis R, Wattie J, Inman MD. Components of airway hyperresponsiveness and their associations with inflammation and remodeling in mice. J Allergy Clin Immunol 2007; 119: 848-854.
43. Boulet LP, Chakir J, Dube J, Laprise C, Boutet M, Laviolette M. Airway inflammation and structural changes in airway hyper-responsiveness and asthma: an overview. Can Respir J 1998; 5: 16-21.
44. Pare PD, McParland BE, Seow CY. Structural basis for exaggerated airway narrowing. Can J Physiol Pharmacol 2007; 85: 653-658.